Vycor Medical IncOTCQB:VYCO
- LAST PRICE0.0756
- TODAY'S CHANGE (%)-0.0107 (-12.4058%)
- Bid / Lots0.0510/ 100
- Ask / Lots0.1000/ 945
- Open / Previous Close0.0880 / 0.0863
- Day Range
- 52 Week Range
- Volume16,000
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | VYCO |
|---|---|---|
| 09:57 ET | 2000 | 0.0511 |
| 10:18 ET | 1000 | 0.0611 |
| 10:33 ET | 2000 | 0.078 |
| 10:38 ET | 10000 | 0.052 |
| 11:18 ET | 1000 | 0.07555 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Vycor Medical Inc | 2.9M | -4.8x | --- |
Nanovibronix Inc | 2.4M | -0.6x | --- |
Reflect Scientific Inc | 4.0M | -134.1x | --- |
Predictive Oncology Inc | 4.6M | -0.2x | --- |
Hawkeye Systems Inc | 2.2M | -2.3x | --- |
Remedent Inc | 999.8K | -3.9x | --- |
Company Information
Vycor Medical, Inc. provides surgical and therapeutic solutions. The Company designs, develops and markets neurological medical devices and therapies. The Company operates through two segments: Vycor Medical and NovaVision. The Vycor Medical segment designs, develops and markets medical devices for use in neurosurgery. The NovaVision segment provides non-invasive rehabilitation therapies for those who have vision disorders resulting from neurological brain damage such as that caused by a stroke. Vycor Medical's product Vycor Medical's ViewSite Brain Access System (VBAS) is a next generation retraction and access system. Vycor Medical focuses on brain and cervical surgical access systems for sale to hospitals and medical professionals. NovaVision's products include Vision Restoration Therapy (VRT), NeuroEyeCoach and Neuro-Eye Therapy (NeEt). The Company operates in the United States and Europe.
Contact Information
- Headquarters
- 951 Broken Sound Parkway, Suite 320BOCA RATON, FL, United States 33487
- Phone
- 562-558-2000
- Fax
- 631-794-2444
Executives
- Chairman of the Board, Chief Financial Officer
- Adrian Liddell
- Director
- David Cantor
- Chief Executive Officer, Executive Vice President, Director
- Peter Zachariou
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.9M |
|---|---|
Revenue (TTM) | $1.4M |
Shares Outstanding | 33.4M |
Vycor Medical Inc does not pay a dividend. | |
Beta | 0.51 |
EPS | $-0.02 |
Book Value | $-0.10 |
P/E Ratio | -4.8x |
Price/Sales (TTM) | 2.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -6.42% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
